13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 24 holding rows worth $218,758,977.
- Accession
- 0001826434-24-000002
- Filer
- CIK 1826434
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 24 entries on the cover page, a total value of $218,758,977 stated on the cover page (in dollars after the unit check, H1), rows summing to $218,758,977 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AbbVie,Inc. | 00287Y109 | COM | 167,807 | $26,005,051 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,794,335 | $18,732,857 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 698,800 | $15,045,164 | dollars as filed | put |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 16,012 | $14,063,179 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 171,676 | $13,273,988 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 99,550 | $12,538,323 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 839,933 | $11,859,854 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 45,814 | $11,855,289 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 261,797 | $11,762,539 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 130,738 | $10,405,437 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 225,564 | $10,389,478 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 24,182 | $9,199,558 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 141,847 | $8,885,296 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 102,215 | $6,150,277 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 25,524 | $5,905,743 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 293,112 | $5,827,067 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 248,761 | $5,542,395 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 542,945 | $4,169,818 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 58,787 | $3,959,304 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 207,147 | $3,894,364 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 110,470 | $3,483,119 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 275,482 | $2,900,825 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 47,604 | $2,874,806 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 36,150 | $35,246 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-24-000002 | this filing | 2024-02-14 | acceptance time not in the bulk data set |